NO171275C - Analogifremgangsmaate for fremstilling av synisomerer av terapeutisk aktive 3-cefem-4-karboksylsyrederivater med forbedrede farmakokinetika - Google Patents

Analogifremgangsmaate for fremstilling av synisomerer av terapeutisk aktive 3-cefem-4-karboksylsyrederivater med forbedrede farmakokinetika

Info

Publication number
NO171275C
NO171275C NO884486A NO884486A NO171275C NO 171275 C NO171275 C NO 171275C NO 884486 A NO884486 A NO 884486A NO 884486 A NO884486 A NO 884486A NO 171275 C NO171275 C NO 171275C
Authority
NO
Norway
Prior art keywords
synisomers
cefem
preparing
carboxylic acid
acid derivatives
Prior art date
Application number
NO884486A
Other languages
English (en)
Norwegian (no)
Other versions
NO171275B (no
NO884486L (no
NO884486D0 (no
Inventor
Bernard Labeeuw
Ali Salhi
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO884486D0 publication Critical patent/NO884486D0/no
Publication of NO884486L publication Critical patent/NO884486L/no
Priority to NO923007A priority Critical patent/NO923007D0/no
Publication of NO171275B publication Critical patent/NO171275B/no
Publication of NO171275C publication Critical patent/NO171275C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/31—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/32—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NO884486A 1987-10-08 1988-10-07 Analogifremgangsmaate for fremstilling av synisomerer av terapeutisk aktive 3-cefem-4-karboksylsyrederivater med forbedrede farmakokinetika NO171275C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO923007A NO923007D0 (no) 1987-10-08 1992-07-30 Mellomprodukt til bruk ved fremstilling av synisomerer avterapeutisk aktive 3-cefem-4-karboksylsyrederivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8713925A FR2621589B1 (fr) 1987-10-08 1987-10-08 Derives des cephalosporines a pharmacocinetique amelioree, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (4)

Publication Number Publication Date
NO884486D0 NO884486D0 (no) 1988-10-07
NO884486L NO884486L (no) 1989-04-10
NO171275B NO171275B (no) 1992-11-09
NO171275C true NO171275C (no) 1993-02-17

Family

ID=9355637

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884486A NO171275C (no) 1987-10-08 1988-10-07 Analogifremgangsmaate for fremstilling av synisomerer av terapeutisk aktive 3-cefem-4-karboksylsyrederivater med forbedrede farmakokinetika

Country Status (19)

Country Link
US (1) US5079241A (pt)
EP (1) EP0311521B1 (pt)
JP (1) JPH0637502B2 (pt)
KR (1) KR970004044B1 (pt)
AR (1) AR246271A1 (pt)
AT (1) ATE74607T1 (pt)
AU (2) AU612414B2 (pt)
DE (1) DE3869895D1 (pt)
DK (1) DK555288A (pt)
ES (1) ES2036702T3 (pt)
FI (1) FI89715C (pt)
FR (1) FR2621589B1 (pt)
GR (1) GR3005122T3 (pt)
IE (1) IE61508B1 (pt)
IL (2) IL103721A (pt)
NO (1) NO171275C (pt)
NZ (1) NZ226487A (pt)
PT (1) PT88694B (pt)
ZA (1) ZA887546B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4282699B2 (ja) 2006-09-01 2009-06-24 株式会社東芝 半導体装置
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024133A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4033950A (en) * 1971-05-14 1977-07-05 Glaxo Laboratories Limited 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4138555A (en) * 1971-05-14 1979-02-06 Glaxo Laboratories, Limited (6R,7R)-7-[2-aryl-2-(etherified oximino)acetamido]-3-carbamoyloxymethylceph-3-em-4-carboxylic acid 1-oxides
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4203899A (en) * 1974-12-19 1980-05-20 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
JPS5760345B2 (pt) * 1974-12-19 1982-12-18 Takeda Chemical Industries Ltd
US4668783A (en) * 1974-12-19 1987-05-26 Takeda Chemical Industries, Ltd. Thiazolylacetamido cephalosporin compounds
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
US4871860A (en) * 1976-04-12 1989-10-03 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-caroxylic acid compounds and processes for the preparation thereof
US4493833A (en) * 1976-04-12 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds
US4304770A (en) * 1976-04-12 1981-12-08 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4331664A (en) * 1976-04-12 1982-05-25 Fujisawa Pharmaceutical Co., Ltd. Syn isomer of 7-[2-cyclo(lower) alkoxyimino-2-(2-amino-or substituted aminothiazol-4-yl)acetamido]-3-lower alkanoyloxymethyl or heterocyclicthiomethyl-3-cephem-4-carboxylic acid compounds
US4804752A (en) * 1976-04-12 1989-02-14 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4364943A (en) * 1976-04-12 1982-12-21 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 7-[2-alkoxyimino-2-(2-amino-alkanoylamino-or haloalkanoylamino-thiazol-4-yl) acetamids]-3-[hexanoyl-, or phenylalkanoyl-oxymethyl or benzothiazolylthiomethyl]-3-cephem-4-carboxylic acid
DE2760484C2 (pt) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4655166A (en) * 1979-12-26 1987-04-07 Hitachi, Ltd. Apparatus for preventing oscillation of running strip
FR2546520B1 (fr) * 1983-05-27 1985-08-30 Sanofi Sa Nouveaux composes antibiotiques derives des cephalosporines
FR2570702B1 (fr) * 1984-09-27 1987-01-09 Sanofi Sa Derives des cephalosporines, procedes d'obtention et leur application a titre d'antibiotiques
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
FR2607135B1 (fr) * 1986-11-20 1989-04-28 Sanofi Sa Nouveaux derives des cephalosporines a pharmacocinetique amelioree, procede pour leur preparation et compositions pharmaceutiques les contenant
ZA884093B (en) * 1987-06-16 1989-04-26 Hoffmann La Roche Acyl derivatives

Also Published As

Publication number Publication date
PT88694A (pt) 1988-11-01
AU2349588A (en) 1989-04-13
KR970004044B1 (ko) 1997-03-24
JPH0637502B2 (ja) 1994-05-18
AU637915B2 (en) 1993-06-10
IL87975A0 (en) 1989-03-31
GR3005122T3 (pt) 1993-05-24
ZA887546B (en) 1989-06-28
DK555288A (da) 1989-04-09
IL103721A (en) 1994-06-24
NO171275B (no) 1992-11-09
FI884614A0 (fi) 1988-10-07
DE3869895D1 (de) 1992-05-14
FI89715B (fi) 1993-07-30
NO884486L (no) 1989-04-10
NZ226487A (en) 1990-08-28
IL87975A (en) 1993-04-04
AU612414B2 (en) 1991-07-11
FR2621589A1 (fr) 1989-04-14
AU7945191A (en) 1991-09-12
PT88694B (pt) 1992-12-31
FR2621589B1 (fr) 1990-03-02
IE61508B1 (en) 1994-11-02
ES2036702T3 (es) 1993-06-01
IE883046L (en) 1989-04-08
KR890006656A (ko) 1989-06-15
US5079241A (en) 1992-01-07
NO884486D0 (no) 1988-10-07
DK555288D0 (da) 1988-10-04
FI884614A (fi) 1989-04-09
EP0311521B1 (fr) 1992-04-08
JPH01128985A (ja) 1989-05-22
FI89715C (fi) 1993-11-10
EP0311521A1 (fr) 1989-04-12
AR246271A1 (es) 1994-07-29
ATE74607T1 (de) 1992-04-15

Similar Documents

Publication Publication Date Title
NO169900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater
NO882732L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO169439C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler
NO864425L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO170480C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater
NO172048C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazoler
NO176319C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater
NO851695L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater
NO171214C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater
NO874955D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO893270L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater.
NO176713C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater
NO172575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
NO170976C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO169648C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
NO884175L (no) Fremgangsmaate for fremstilling av terapeutiske aktive heterocykliske derivater.
NO173330C (no) Anologifremgangsm}te for fremstilling av terapeutisk aktive pyrrolidin-derivater
NO171108C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater